Back to search

Article

Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade

2023-11-07

Abstract excerpt

<h4>Background: </h4> Fibrolamellar carcinoma (FLC) is a rare liver tumor driven by the DNAJ-PKAc fusion protein that affects healthy young patients. Little is known about the immune response to FLC, limiting rational design of immunotherapy. <h4>Methods: </h4>: Multiplex immunohistochemistry and gene expression profiling were performed to characterize the FLC tumor immune microenvironment and adjacent non-tumor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6a6ad390-261b-5960-8da3-b2f63f2370cd
DOI
10.21203/rs.3.rs-3495912/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockadeDOI 10.21203/rs.3.rs-3495912/v1
Select a neighboring publication to make it the new centre.